Skip to main content
OpenTrials
Completed

NCT Number: NCT00280943

Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities

Osteoporotic fractures of the hip are a major cause of admission to long-term care facilities. Such fractures put patients at high risk for further fractures, pain and disability. Current data show that many patients in long-term care facilities do not receive FDA medications for their osteoporosis. This trial will test whether a multi-model intervention (which provides feedback about provider use of osteoporosis medications, information about osteoporosis, and currently approved osteoporosis medications)directed at physicians, other health care providers, and nurses will improve the number of prescriptions written for FDA approved medications for osteoporosis treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Fractures Bone Diseases Bone Diseases, Metabolic Femoral Fractures Fractures, Bone Hip Injuries Leg Injuries Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Osteoporosis Wounds and Injuries

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any North Carolina long-term care facility with ten residents who had had a hip fracture or osteoporosis diagnosis

Treatment and study plan

Long-term care facilities in the intervention arm will receive education and feedback audit on performance

Behavioral

Primary outcomes

  1. Number of new prescriptions for FDA-Approved osteoporosis medications.

Secondary outcomes

  1. Secondary Outcome Measures: Changes in number of bone mineral density test ordered, change in the number of hip protectors issued, change in the number of prescriptions for calcium and vitamin D, changes in the rate of new osteoporotic fractures.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities Written for FDA Approved Medications for Osteoporosis Treatment.

Important dates

Study start
2005
Study completion
2007
First posted
Jan 24, 2006
Registry last updated
Oct 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.